DYNE THERAPEUTICS INC. - COMMON STOCK
32.58
04-10月-24 14:59:59
15 分の遅延
株式
-0.97
-2.89%
本日の幅
32.39 - 34.00
ISIN
N/A
ソース
NASDAQ
-
20 3 2023 06:30:24 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Upcoming Investor Conferences
07 3 2023 06:30:00 提供 Nasdaq GlobeNewswire
-
02 3 2023 06:30:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference
03 1 2023 06:30:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights
03 11 2022 06:30:01 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Investor Conferences in November
02 11 2022 06:30:00 提供 Nasdaq GlobeNewswire
-
31 10 2022 06:30:00 提供 Nasdaq GlobeNewswire
-
11 10 2022 15:10:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Chardan’s 6th Annual Genetic Medicines Conference
27 9 2022 06:30:00 提供 Nasdaq GlobeNewswire
-
12 9 2022 06:00:01 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Morgan Stanley 20th Annual Global Healthcare Conference
06 9 2022 15:30:00 提供 Nasdaq GlobeNewswire
-
06 9 2022 06:01:00 提供 Nasdaq GlobeNewswire
-
06 9 2022 06:00:01 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics Appoints Francesco Bibbiani, M.D., as Senior Vice President, Head of Development
29 8 2022 06:30:00 提供 Nasdaq GlobeNewswire
-
10 8 2022 06:30:41 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights
04 8 2022 06:30:01 提供 Nasdaq GlobeNewswire
-
12 7 2022 06:30:00 提供 Nasdaq GlobeNewswire
-
05 7 2022 06:30:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Jefferies Global Healthcare Conference
03 6 2022 06:30:00 提供 Nasdaq GlobeNewswire
-
16 5 2022 06:30:00 提供 Nasdaq GlobeNewswire